Human umbilical cord vein as a source of osteoblastic cells
DOI:
https://doi.org/10.14295/bds.2014.v17i3.986Abstract
Objective: Regenerative medicine and tissue engineering are searching for novel stem cell based therapeutic strategies that will allow for efficient treatment or even potential replacement of damaged organs. The purpose of this work was to study the behaviour of human umbilical cord vein cells (UCVs) through osteoblastic differentiation. Material and Methods: Cells were isolated, expanded and cultivated in osteogenic medium. After 7, 14 and 21 days of culture, there were evaluated cell morphology, proliferation, viability and alkaline phosphatase (ALP) activity. Immunolocalization of ALP was performed after 1, 7 and 14 days of culture and cells were analysed in a fluorescence microscope. Statistical test utilized was Mann-Whitney (p<0.05). Results: The results showed that osteogenic medium induced morphological changes in the UCVs. Besides, it permited cell viability and proliferation, as well as an increase in the alkaline phosphatase expression and activity. Conclusion: It is concluded that these cells can differentiate into osteoblastic-like cells, contributing to applications for cell therapy and tissue engineering.
Downloads
Published
Issue
Section
License
COPYRIGHT TRANSFER AND RESPONSIBILITY STATEMENT
(PDF)
For all articles published in the BDS journal, copyright is retained by the authors. Articles are licensed under an open-access Creative Commons CC BY 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted, provided that the original published version is cited. These conditions allow for maximum use and exposure of the work while ensuring that the authors receive proper credit. All metadata associated with published articles is released under the Creative Commons CC0 Universal Public Domain Dedication.
Before the submission, authors must obtain permission to reproduce any published material (figures, schemes, tables, or any extract of a text) that does not fall into the public domain or for which they do not hold the copyright. Permission should be requested by the authors from the copyright holder (usually the Publisher, please refer to the imprint of the individual publications to identify the copyright holder).
The authors hereby attest that the study is original and does not present manipulated data, fraud, or plagiarism. All names listed made a significant scientific contribution to the study, are aware of the presented data, and agree with the final version of the manuscript. They assume complete responsibility for the ethical aspects of the study.
This text must be printed and signed by all authors. The scanned version should be submitted as supplemental file during the submission process.